Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV01C vs Comirnaty Booster in Previously Vaccinated (Laos Study)
NCT05239975Phase 2Withdrawn
- Sponsor
- Sinocelltech Group Limited
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of sctv01c in coronavirus disease 2019 (COVID-19), sponsored by Sinocelltech Group Limited. Planned start Apr 2022; status: withdrawn.
02
Drugs
sctv01c
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05239975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05239975.